MX169374B - PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA - Google Patents

PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA

Info

Publication number
MX169374B
MX169374B MX1418888A MX1418888A MX169374B MX 169374 B MX169374 B MX 169374B MX 1418888 A MX1418888 A MX 1418888A MX 1418888 A MX1418888 A MX 1418888A MX 169374 B MX169374 B MX 169374B
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
bacteria
viruses
procedure
preparation
Prior art date
Application number
MX1418888A
Other languages
Spanish (es)
Inventor
Dale Bordt
Hans Draayer
Original Assignee
Beecham Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Inc filed Critical Beecham Inc
Priority to MX1418888A priority Critical patent/MX169374B/en
Publication of MX169374B publication Critical patent/MX169374B/en

Links

Landscapes

  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a un procedimiento para preparar una composición farmaceutica livre de virus o bacterias vivas, que comprende mezclar un virus o bacteria inactivada com un portador farmaceuticamente aceptable, el procedimiento está caracterizado porque el virus o bacteria inactivada se prepara inactivando el virus o bacteria viva con ácido ascórbico y/o una sal del mismo, en presencia de oxígeno y de una fuente de iones de metales pesados.The present invention relates to a method for preparing a free pharmaceutical composition of live viruses or bacteria, which comprises mixing an inactivated virus or bacteria with a pharmaceutically acceptable carrier, the method is characterized in that the inactivated virus or bacteria is prepared by inactivating the virus or live bacteria with ascorbic acid and / or a salt thereof, in the presence of oxygen and a source of heavy metal ions.

MX1418888A 1988-12-15 1988-12-15 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA MX169374B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX1418888A MX169374B (en) 1988-12-15 1988-12-15 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX1418888A MX169374B (en) 1988-12-15 1988-12-15 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA

Publications (1)

Publication Number Publication Date
MX169374B true MX169374B (en) 1993-06-30

Family

ID=19742180

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1418888A MX169374B (en) 1988-12-15 1988-12-15 PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA

Country Status (1)

Country Link
MX (1) MX169374B (en)

Similar Documents

Publication Publication Date Title
AU2284388A (en) A vaccine substantially free from live viruses or bacteria
SE8300623L (en) PHARMACEUTICAL COMPOSITION CONTAINING STABLE MICROCRISTALLIN CIS-PLATINA (II) -DIAMMINE DICHLORIDE (CISPLATIN)
ES8705764A1 (en) Photodynamic inactivation of virus in therapeutic protein compositions.
ES2057191T5 (en) PRODUCTION METHOD FOR A COMPOSITION CONTAINING PROTEINS.
HU9201258D0 (en) Process for the production of medical preparations for treating hiv infections and of their active agents
EP4445900A3 (en) Therapeutic compounds for hiv virus infection
DK0531413T3 (en) An antiviral preparation containing prostratin
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
MX169374B (en) PROCEDURE FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FREE OF VIRUSES OR LIVE BACTERIA
ES2058100T3 (en) COMBINED VACCINE.
BG93114A (en) 1,8 BENZONAPHTHYRIDINE DERIVATIVES, METHODS OF THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
ES2175449T3 (en) PROCEDURE FOR THE DEACTIVATION OF VIRUSES WRAPPED BY LIPIDS, WITH LIPOPEPTIDES, AND NEW ANTIVIRICAL LIPOPEPTIDES.
Mead et al. Effect of human, recombinant interleukin 2 on Punta Toro virus infections in C57BL/6 mice
UA42693C2 (en) The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus.
BG102266A (en) Method for the preparation of solid batched forms having very low doses of the medicamentous form
RU94045140A (en) Pharmaceutical composition for prophylaxis and treatment of viral diseases, method of its preparing and use of bradykinin antagonist or its physiologically tolerant salt as agent for prophylaxis and treatment of viral diseases
GB1385563A (en) Aminophthalazine derivatives and pharmaceutical uses thereof
AU660916B2 (en) Beta-hydroxamate D-aspartic acid for treatment of viral infections and tumours
GB1235053A (en) New organic acid and process for its preparation
SU1565027A1 (en) Inactivating agent of the west nile virus
JPS5756431A (en) Inactivated vaccine for infectious disease caused by canine adenovirus type-2
BR9708720A (en) Pharmaceutical composition and process for the treatment of HIV dementia.
GEP19991709B (en) Antipurulent Infection Consortium of Bacteriophage Strains
UA19093A (en) Method for producing biologically active preparation
CO4180391A1 (en) HIGH-POWERED VACCINE